Strategic Buy Lights Up This Biotech Stock: Time to Invest?

Illumina TodayILMNIllumina$116.56 +0.47 (+0.40$89.00▼$195.64Price Target$158.57Add to WatchlistLife sciences company Illumina Inc. NASDAQ: ILMN stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. This comes after its divestiture and spin-off of GRAIL, LLC NASDAQ: GRAL on June 24, 2024. Illumina had previously acquired the early detection cancer testing company for $8 billion in 2021.Get Illumina alerts:Illumina's GRAIL Acquisition Backfired, Resulting i ...